Clinical trial
Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKD in Japan
NCT02847624 is registered in ClinicalTrials.gov with Otsuka Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKD in Japan
- Lead sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 24, 2014
- Completion date
- September 20, 2022
- Enrollment
- 1,802 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.